Interview with Heather Armoogam What is a personal board of directors?Is a board of directors essential for everyone?Is it necessary for it to come from within your company? This episode is all about career advice. Together with Heather, we talk about having your personal board of directors and how could

We all need to present frequently and the more you progress with your career the more important the presentations become. Messing these presentations up – especially in front of those responsible for your next promotion – will lead to bad career outcomes. In today’s episode, Benjamin and I review 9

Interview with Guillaume Desachy and Nicole Krämer Interview with Guillaume Desachy and Nicole Krämer Biomarkers help you in all kinds of different ways, so stay tuned while Guillaume, Nicole, and I talk about the following points:

Today’s episode is an extract from my interview with Jenn Fenwick, who’s also a podcaster like me and we talk about my career and leadership. This is a fun chat where we talk about navigating fear, opening ourselves up to vulnerability and making courageous decisions… oh and Beyoncé gets a

Interview with Andrew Thomson What is extrapolation?How can we use extrapolation in paediatrics?What are the main challenges? Paediatric research always comes with challenges, and understanding paediatric submission is vital. There’s always a lack of treatment in this area. In this episode, you’ll understand what you can do to get evidence

Why are we raving about this conference?Why is this the best conference I have been attending?What are the other activities beside the scientific part of the conference? This is a special episode while Benjamin and I talk about the upcoming PSI conference and what you can expect from it. This

Interview with Rachael Lawrance The FDA is developing a series of four methodological patient-focused drug development (PFDD) guidance documents to address, in a stepwise manner, how stakeholders can collect and submit patient experience data and other relevant information from patients and caregivers for medical product development and regulatory decision making.

Interview with Dr. Stefan Walzer What is a DIGA?Why is Germany so important for DIGAs? Nowadays, there are a couple of available apps being used in several countries that collect user information, such as heart rate combined with algorithms that calculate certain health risks that the user may be vulnerable

Interview with Antoine Regnault Why do companies want to develop new patient-reported outcomes (PRO)?How does the process start when we want to develop a new questionnaire?What are the key areas to look into for understanding the quality of a PRO?What guidelines exist on developing new PROs? In today’s episode, Antoine

Interview with Jenny Devenport What is medical affairs? Launch and Lifecycle?How has this area evolved over the last 2 decades?What is the current state across the industry in terms of the role of statistics in this space? This is a series of episodes and today’s content is the first episode.

Interview with Miguel Hernan When there is one topic, which is really hot, it’s causal inference. I’ve got in contact with it about 20 years ago when analysing observational studies and when nobody working on clinical trials would consider it. But now – after the introduction of the estimands framework